Abstract:Cardiovascular disease (CVD), and in particular coronary artery heart disease (CAHD), is the leading cause of morbidity and mortality in women. Until recently, most of our knowledge about the pathophysiology of CVD in women - and, subsequently, management guidelines - were based on studies conducted mostly in men. While similar mechanisms operate to induce CVD in women and men, gender-related differences exist in the anatomy and physiology of the myocardium, and sex hormones modify the course of disease in women. Women, more than men, have their initial manifestation of CAHD as angina pectoris; are likely to be referred for diagnostic tests at a more advanced stage of disease, and are less likely than men to have corrective invasive procedures. The overall morbidity and mortality following the initial ischaemic heart event is worse in women, and the case fatality rate is greater in women than in men. Also, the relative impact of impaired vasoreactivity of the coronary artery, increased viscosity of the blood and dysregulation of automaticity and arrhythmia, is greater in women than in men. The most effective means of decreasing the impact of CVD on women's health is by an active approach from childhood to proper principles of healthcare in order to modify the contribution of specific risk factors. The latter include obesity, abnormal plasma lipid profile, hypertension, diabetes mellitus, cigarette smoking, sedentary lifestyle, increased blood viscosity, augmented platelet aggregability, stress and autonomic imbalance. The use of lipid-lowering drugs has not been adequately studied in women but reports from studies conducted mostly in men do predict an advantage also to women. Oestrogen deficiency after spontaneous or medically induced menopause is an important risk factor for CVD and CAHD. Observational and mechanistic data suggest a role for oestrogen replacement after menopause for primary, and possibly secondary, prevention of CVD. However, two recent prospective trials suggest that treatment de novo with hormone replacement of older post-menopausal women after an acute coronary event may not confer cardiovascular protection and may increase the risk of thromboembolic disease. Results of ongoing long-term studies may determine the beneficial role of hormone replacement versus potential risks involved with this treatment.

The complexity of cardiovascular risk in women. Descriptive review

Understanding the spectrum of cardiovascular risk in women - A primer for prevention

Addressing the Global Burden of Cardiovascular Disease in Women: JACC State-of-the-Art Review

Update on sex specific risk factors in cardiovascular disease

Cardiovascular Disease and the Female Disadvantage

Sex-specific differences in cardiovascular risk factors and implications for cardiovascular disease prevention in women

Cardiovascular diseases in women: a differentiated view and risk stratification

Do Women Suffer from Them Differently?

Unique cardiometabolic factors in women that contribute to modified cardiovascular disease risk

Primary prevention of cardiovascular disease in women

Awareness and Knowledge of Cardiovascular Diseases and Its Risk Factors Among Women of Reproductive Age: A Scoping Review

Vascular Aging in Women

Update on cardiovascular disease in post-menopausal women

Cardiovascular prevention in women: a narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease'

Cardiometabolic risk factors in women: what's sauce for the goose is not sauce for the gander

Cardiovascular Disease in Women and the Role of Hormone Replacement Therapy

Female-specific risk factors for cardiovascular disease: an update

Closing the gap: cardiovascular disease in women

Multidisciplinary management of cardiovascular disease in women: Delphi consensus

Cardiac Health and Diabetes Mellitus in Women: Problems and Prospects.

Engaging women in decision-making about their heart health: a literature review with patients' perspective